What is the pathophysiology of small intestinal bacterial overgrowth (SIBO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pathophysiology of SIBO

SIBO develops when protective mechanisms that normally prevent bacterial colonization of the small intestine fail, allowing colonic bacteria to proliferate in stagnant loops of bowel, leading to malabsorption through bile salt deconjugation and pancreatic enzyme degradation 1.

Core Protective Mechanisms That Fail in SIBO

The small intestine normally maintains bacterial concentrations below 10⁴ colony forming units (cfu)/mL through several endogenous defense mechanisms 1, 2:

  • Gastric acid secretion - Creates hostile environment for bacteria
  • Intestinal motility and the Migrating Myoelectric Complex (MMC) - Clears debris and prevents stasis
  • Intact ileocecal valve - Prevents retrograde bacterial migration from colon
  • Intestinal immunoglobulin secretion - Provides immune surveillance
  • Bacteriostatic properties of pancreatic and biliary secretions - Directly inhibit bacterial growth

When one or more of these mechanisms becomes impaired, the aetiology of SIBO is usually complex and multifactorial 1.

The Pathophysiological Cascade

1. Impaired MMC and Gut Stasis

When the MMC is disrupted, the small bowel cannot clear debris, predisposing to gut stasis and bacterial overgrowth 1. This occurs through:

  • Loss of coordinated gut contractions
  • Failure of forward propulsion causing constipation
  • Dilated gut with reduced propulsion
  • Accumulation of chyme triggering severe painful non-propulsive contractions (explaining postprandial abdominal pain)

2. Bacterial Proliferation in Stagnant Loops

The combination of dilated gut with reduced propulsion and ineffective MMC allows anaerobic bacteria to proliferate in stagnant loops of bowel 1. The normal small intestinal bacterial concentration of <10⁴ cfu/mL increases dramatically, with >10⁶ cfu/mL conventionally regarded as diagnostic 2.

3. Metabolic Consequences of Bacterial Overgrowth

The proliferating bacteria cause malabsorption through direct metabolic effects 1:

Bile salt deconjugation:

  • Bacteria deconjugate bile salts
  • Less effective secondary bile acids (e.g., lithocholic acid) are produced
  • Results in steatorrhea and malnutrition

Pancreatic enzyme degradation:

  • Bacterial enzymes degrade pancreatic lipase, amylase, and trypsin
  • Further impairs digestion of fats, carbohydrates, and proteins

Fat-soluble vitamin malabsorption:

  • Vitamins A and E primarily affected (less so D, rarely K)
  • Causes night blindness, poor color vision, dry flaky skin, and ataxia

Vitamin B12 malabsorption:

  • Bacteria consume B12 before host absorption
  • Paradoxically, folic acid and vitamin K may be manufactured by bacteria, giving rise to high serum levels

4. Toxic Bacterial Metabolites

Bacteria can produce pathological metabolites 1:

  • D-lactic acid (normally L-isomer) → D-lactic acidosis with high anion gap
  • Ammonia → elevated blood ammonia levels
  • Excessive fermentation → gas production, bloating, and distension

5. Mucosal Damage

SIBO leads to a malabsorption syndrome with occasionally protein-losing enteropathy 1. Subtotal villous atrophy may be found on histology, demonstrating direct mucosal injury from bacterial overgrowth.

Clinical Context and Predisposing Factors

SIBO occurs most commonly in patients with 1, 2, 3:

  • Anatomical abnormalities: Bowel obstruction, diverticula, surgical alterations, blind loops
  • Motility disorders: Enteric neuropathies, chronic intestinal pseudo-obstruction, diabetes
  • Achlorhydria: Proton pump inhibitor use, atrophic gastritis, advanced age
  • Immunosuppression: Reduced intestinal immunoglobulin secretion
  • Pancreatic insufficiency: Loss of bacteriostatic pancreatic secretions 4

Important Caveats

The pathophysiological framework described above applies to "classical" SIBO in the context of maldigestion/malabsorption 5, 6. The extension of SIBO diagnosis to explain symptoms in irritable bowel syndrome and other functional disorders lacks the same pathophysiological plausibility 5, 6. Breath tests used in these contexts are subject to misinterpretation, and the clinical relevance of bacterial overgrowth detected in apparently healthy individuals remains unclear 2, 6.

The undernutrition resulting from SIBO creates a vicious cycle: malabsorption leads to mucosal atrophy, reduced gastric acid and pancreatic enzyme secretion, and more bacterial colonization of the upper gut 1.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.